A Trial to Investigate Single Dose Pharmacokinetics of NNC0148-0287sema in a Fixed Ratio Compared With Insulin 287 and Semaglutide Given Separately in Subjects With Type 2 Diabetes
Latest Information Update: 14 Nov 2024
At a glance
- Drugs Insulin icodec (Primary) ; Semaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 22 Oct 2019 Status changed from active, no longer recruiting to completed.
- 09 May 2019 Status changed from recruiting to active, no longer recruiting.
- 22 Jan 2019 Status changed from not yet recruiting to recruiting.